ReviewPharmaceutics2022

The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer's Disease.

Ancuta-Veronica Lupaescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.